{"count": 3, "results": [{"_id": "37144032", "pmid": 37144032, "pmcid": "PMC10151496", "title": "Premorbid use of selective beta-blockers improves sepsis incidence and course: Human cohort and animal model studies", "journal": "Front Med (Lausanne)", "authors": ["Hong SY", "Lai CC", "Teng NC", "Chen CH", "Hsu CC", "Chan NJ", "Wang CY", "Wang YH", "Lin YS", "Chen L"], "date": "2023-04-18T00:00:00Z", "doi": "10.3389/fmed.2023.1105894", "meta_date_publication": "2023", "meta_volume": "10", "meta_issue": "", "meta_pages": "1105894", "score": 50287.004, "text_hl": "To the best of our knowledge, this is the first study showing the beneficial effects of selective beta-blockers, particularly @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@, on @<m>DISEASE_Sepsis</m> @DISEASE_MESH:D018805 @@@sepsis@@@.", "citations": {"NLM": "Hong SY, Lai CC, Teng NC, Chen CH, Hsu CC, Chan NJ, Wang CY, Wang YH, Lin YS, Chen L. Premorbid use of selective beta-blockers improves sepsis incidence and course: Human cohort and animal model studies Front Med (Lausanne). 2023;10():1105894. PMID: 37144032", "BibTeX": "@article{37144032, title={Premorbid use of selective beta-blockers improves sepsis incidence and course: Human cohort and animal model studies}, author={Hong SY and Lai CC and Teng NC and Chen CH and Hsu CC and Chan NJ and Wang CY and Wang YH and Lin YS and Chen L}, journal={Front Med (Lausanne)}, volume={10}, pages={1105894}}"}}, {"_id": "31939847", "pmid": 31939847, "title": "Heart Rate Control during Experimental Sepsis in Mice: Comparison of Ivabradine and beta-Blockers.", "journal": "Anesthesiology", "authors": ["Bedet A", "Voiriot G", "Ternacle J", "Marcos E", "Adnot S", "Derumeaux G", "Mekontso Dessap A"], "date": "2020-02-01T00:00:00Z", "doi": "10.1097/ALN.0000000000003045", "meta_date_publication": "2020 Feb", "meta_volume": "132", "meta_issue": "2", "meta_pages": "321-329", "score": 50260.902, "text_hl": "There was no difference in survival 60 h after @<m>DISEASE_Sepsis</m> @DISEASE_MESH:D018805 @@@sepsis@@@ induction with @CHEMICAL_Ivabradine @CHEMICAL_MESH:D000077550 @@@ivabradine@@@ (6 of 20, 30%) or @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ (7 of 20, 35%), as compared with placebo (5 of 20, 25%; P = 0.224). ", "citations": {"NLM": "Bedet A, Voiriot G, Ternacle J, Marcos E, Adnot S, Derumeaux G, Mekontso Dessap A. Heart Rate Control during Experimental Sepsis in Mice: Comparison of Ivabradine and beta-Blockers. Anesthesiology. 2020 Feb;132(2):321-329. PMID: 31939847", "BibTeX": "@article{31939847, title={Heart Rate Control during Experimental Sepsis in Mice: Comparison of Ivabradine and beta-Blockers.}, author={Bedet A and Voiriot G and Ternacle J and Marcos E and Adnot S and Derumeaux G and Mekontso Dessap A}, journal={Anesthesiology}, volume={132}, number={2}, pages={321-329}}"}}, {"_id": "36920635", "pmid": 36920635, "title": "Single-cell Sequence Analysis Combined with Multiple Machine Learning to Identify Markers in Sepsis Patients: LILRA5.", "journal": "Inflammation", "authors": ["Ning J", "Fan X", "Sun K", "Wang X", "Li H", "Jia K", "Ma C"], "date": "2023-03-15T00:00:00Z", "doi": "10.1007/s10753-023-01803-8", "meta_date_publication": "2023 Mar 15", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50256.633, "text_hl": "Molecular docking results demonstrated the possibility of @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ targeting @GENE_LILRA5 @GENE_353514 @@@LILRA5@@@ for the treatment of @<m>DISEASE_Sepsis</m> @DISEASE_MESH:D018805 @@@sepsis@@@. ", "citations": {"NLM": "Ning J, Fan X, Sun K, Wang X, Li H, Jia K, Ma C. Single-cell Sequence Analysis Combined with Multiple Machine Learning to Identify Markers in Sepsis Patients: LILRA5. Inflammation. 2023 Mar 15;():. PMID: 36920635", "BibTeX": "@article{36920635, title={Single-cell Sequence Analysis Combined with Multiple Machine Learning to Identify Markers in Sepsis Patients: LILRA5.}, author={Ning J and Fan X and Sun K and Wang X and Li H and Jia K and Ma C}, journal={Inflammation}}"}}]}